Cannabis-oriented telemedicine platform, NuggMD, announced Monday it will offer free online medical marijuana evaluations to veterans in Oklahoma.
Until 10 p.m Monday night, any Oklahoma veteran with a valid proof of service can get the evaluation.
The service will be user-friendly, as veterans would be given an opportunity to talk with a NuggMD support representative via live chat and ask for evaluation, the company said.
"None of us would enjoy the freedom and prosperity that we do today without our brave veterans," NuggMD co-founder Alex Milligan said in a statement. "We are offering completely free medical marijuana evaluations to Oklahoma's veterans this Monday in humble thanks for their service and sacrifice."
Veterans Day Deals: Businesses Say Thanks With Free Coffee, Pizza, Clothing And Dental Work
Since NuggMD’s foundation back in 2016, its associated physicians have conducted almost a half a million medical marijuana evaluations, across Nevada, California and New York.
"The past seven weeks in Oklahoma have been amazing," NuggMD co-founder Kam Babazade said. "Response to our telemedicine services have far exceeded our expectations, and we're very excited to see what 2020 will bring for the Midwest."
The main advantage of NuggMD’s platform is that allows patients to get their evaluation without leaving their home.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.